Comparison of ketamine, 7, 8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression

J Zhang, W Yao, C Dong, C Yang, Q Ren, M Ma… - …, 2015 - Springer
Rationale Brain-derived neurotrophic factor (BDNF) and signaling at its receptor,
tropomyosin-related kinase B (TrkB), are implicated in the rapid and long-lasting …

A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression

CA Zarate Jr, D Mathews, L Ibrahim, JF Chaves… - Biological …, 2013 - Elsevier
Background The high-affinity N-methyl-D-aspartate (NMDA) antagonist ketamine exerts
rapid antidepressant effects but has psychotomimetic properties. AZD6765 is a low-trapping …

Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders

K Hashimoto, B Malchow, P Falkai… - European archives of …, 2013 - Springer
Severe psychiatric disorders such as schizophrenia are related to cognitive and negative
symptoms, which often are resistant to current treatment approaches. The glutamatergic …

The NMDA receptor complex as a therapeutic target in epilepsy: a review

M Ghasemi, SC Schachter - Epilepsy & Behavior, 2011 - Elsevier
A substantial amount of research has shown that N-methyl-D-aspartate receptors (NMDARs)
may play a key role in the pathophysiology of several neurological diseases, including …

A brief history of antidepressant drug development: from tricyclics to beyond ketamine

VS Pereira, VA Hiroaki-Sato - Acta neuropsychiatrica, 2018 - cambridge.org
ObjectiveAlthough monoaminergic-targeted drugs have prompted great advances in the
development of treatments for depression, the need for new options persists, since these …

Sigma-1 receptor chaperone and brain-derived neurotrophic factor: emerging links between cardiovascular disease and depression

K Hashimoto - Progress in neurobiology, 2013 - Elsevier
Epidemiological studies have demonstrated a close relationship between depression and
cardiovascular disease (CVD). Although it is known that the central nervous system (CNS) …

Meta-analysis of short-and mid-term efficacy of ketamine in unipolar and bipolar depression

B Romeo, W Choucha, P Fossati, JY Rotge - Psychiatry research, 2015 - Elsevier
Among treatments currently assessed in major depression, ketamine, has been proposed of
great interest, especially because of its very rapid action. However, the time-course of the …

Synaptic loss and the pathophysiology of PTSD: implications for ketamine as a prototype novel therapeutic

JH Krystal, CG Abdallah, LA Averill, B Kelmendi… - Current psychiatry …, 2017 - Springer
Abstract Purpose of Review Studies of the neurobiology and treatment of PTSD have
highlighted many aspects of the pathophysiology of this disorder that might be relevant to …

Single iv ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study

YD Hu, YT Xiang, JX Fang, S Zu, S Sha, H Shi… - Psychological …, 2016 - cambridge.org
BackgroundWhile oral antidepressants reach efficacy after weeks, single-dose intravenous
(iv) ketamine has rapid, yet time-limited antidepressant effects. We aimed to determine the …

Essential elements in depression and anxiety. Part I

K Młyniec, CL Davies, IG de Agüero Sánchez… - Pharmacological …, 2014 - Elsevier
Essential elements are very important for the proper functioning of the human body. They
are required for fundamental life processes such as cell division and differentiation and …